Experimental foreign-body associated infections

被引:1
|
作者
Zimmerli, W
机构
来源
关键词
Staphylococcus aureus; device-related infection; ciprofloxacin; fleroxacin; rifampin;
D O I
10.1016/S0399-077X(97)80019-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The problem of implant-associated infection has been an increasing concern since foreign materials were used in surgery. Several animal models have been developed to study different aspects of such infections. The tissue-cage model is especially suitable to analyse the role of antimicrobial agents in device-related infections. This model perfectly simulates the human situation in the sense that no spontaneous healing occurs, and short-term therapy with most antibiotics does not result in the complete elimination of the implant-associated bacteria. Quinolones have been increasingly used in the treatment of device-related bone and joint infections. We therefore studied the role of quinolones against Staphylococcus aureus infection in the foreign-body model. Ln additions, we analysed the effect of rifampin-quinolone combinations. Ciprofloxacin and fleroxacin completely failed to eradicate infections with six clinical isolates of S. aureus. In contrast rifampin alone or in combination was highly efficacious in eliminating tissue-cage associated S. aureus infections. The most important difference between these two types of antibiotics was the complete inability of quinolones to kill stationary-phase staphylococci, whereas rifampin had a good bactericidal activity not only against growing, but also against stationary-phase S. aureus. In conclusion, the experimental data favour the use of rifampin-quinolone combinations in the treatment of implant-associated infections due to S. aureus.
引用
收藏
页码:188 / 194
页数:7
相关论文
共 50 条
  • [1] Experimental foreign-body associated infections
    Zimmerli, W
    MEDECINE ET MALADIES INFECTIEUSES, 1997, 27 : 181 - 187
  • [2] FOREIGN-BODY ASSOCIATED INFECTIONS
    BESNIER, JM
    CHOUTET, P
    MEDECINE ET MALADIES INFECTIEUSES, 1993, 23 (11): : 765 - 767
  • [3] THE PROBLEM OF POLYMER-ASSOCIATED FOREIGN-BODY INFECTIONS
    JANSEN, B
    PETERS, G
    UROLOGE-AUSGABE A, 1991, 30 (05): : 306 - 309
  • [4] PHYSIOPATHOLOGY OF FOREIGN-BODY INFECTIONS
    LEW, DP
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (09): : 1379 - 1382
  • [5] FOREIGN-BODY ASSOCIATED INFECTION
    JANSEN, B
    PETERS, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 : 69 - 75
  • [6] NEW CONCEPTS IN THE PREVENTION OF POLYMER-ASSOCIATED FOREIGN-BODY INFECTIONS
    JANSEN, B
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1990, 272 (04): : 401 - 410
  • [7] NOVEL STRATEGIES FOR THE PREVENTION OF FOREIGN-BODY INFECTIONS
    JANSEN, B
    IMMUNITAT UND INFEKTION, 1992, 20 (06): : 200 - 203
  • [8] Drawbacks of the use of cotrimoxazole in foreign-body infections
    El Haj, Cristina
    Ribera, Alba
    Lloberas, Nuria
    Tubau, Fe
    Ariza, Javier
    Murillo, Oscar
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2018, 36 (06): : 362 - 365
  • [9] EXPERIMENTAL FOREIGN-BODY INFECTION IN MICE
    ESPERSEN, F
    FRIMODTMOLLER, N
    CORNELIUSSEN, L
    ROSDAHL, VT
    SKINHOJ, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 103 - 111
  • [10] FOREIGN-BODY REACTION - EXPERIMENTAL PROTOCOL
    COLEMAN, DL
    KING, RN
    ANDRADE, JD
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1974, 8 (03): : 65 - 76